Literature DB >> 443241

Exogenous hormones and other drug exposures of children with congenital heart disease.

K J Rothman, D C Fyler, A Goldblatt, M B Kreidberg.   

Abstract

A history of oral contraceptive use, hormonal pregnancy tests, prescribed hormones and other drugs was obtained from 390 mothers of infants with congenital heart disease and 1254 mothers of normal infants in Massachusetts. The data show a small positive association between estrogen/progesterone exposure and cardiac malformation, the prevalence ratio estimate of exposed to non-exposed being 1.5 (90 per cent confidence limits are 1.0, 2.1). No association was evident, however, between hormones and trunco-conal or any other class of defect among the cases, an observation which casts doubt on a causal relationship betweem hormones and cardiovascular malformations. Several other drugs were reported more frequently by cases' mothers. These include: ampicillin; aspirin; a combined anti-nausea agent (doxylamine succinate, dicyclomine hydrochloride and pyridoxine hydrochloride); chlordiazopoxide, codeine, diazepam, diphenylhydantoin; insulin; phenobarbital; phenothiazine; phenylephrine; and tetracycline.

Entities:  

Keywords:  Americas; Biology; Congenital Abnormalities--etiology; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Developed Countries; Diseases; Endocrine System; Epidemiologic Methods; Estrogens; Family Planning; Heart Diseases; Hormones; Massachusetts; Maternal-fetal Exchange; Neonatal Diseases And Abnormalities; North America; Northern America; Oral Contraceptives--side effects; Physiology; Pregnancy; Pregnancy, First Trimester; Progestational Hormones; Progesterone; Reproduction; Research Methodology; Retrospective Studies; Studies; United States

Mesh:

Substances:

Year:  1979        PMID: 443241     DOI: 10.1093/oxfordjournals.aje.a112701

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  39 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

2.  Increasing pregnancy-related use of prescribed opioid analgesics.

Authors:  Richard A Epstein; William V Bobo; Peter R Martin; James A Morrow; Wei Wang; Rameela Chandrasekhar; William O Cooper
Journal:  Ann Epidemiol       Date:  2013-08       Impact factor: 3.797

3.  Barriers to contraceptive use in product labeling and practice guidelines.

Authors:  Daniel Grossman; Charlotte Ellertson; Katrina Abuabara; Kelly Blanchard; Francisco T Rivas
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

4.  Case-control study of congenital malformations.

Authors:  J Ananijevic-Pandey; M Jarebinski; B Kastratovic; H Vlajinac; Z Radojkovic; D Brankovic
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

5.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 6.  Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation.

Authors:  Gary A Incaudo
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

7.  Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; James P Rathmell; John D Seeger; Michael Doherty; Michael A Fischer; Krista F Huybrechts
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

Review 8.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

9.  Spermicide use and Down's syndrome.

Authors:  K J Rothman
Journal:  Am J Public Health       Date:  1982-04       Impact factor: 9.308

Review 10.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.